Idiosyncratic drug reactions and membranous glomerulopathy
- PMID: 28137906
- PMCID: PMC5293966
- DOI: 10.1136/bcr-2016-218496
Idiosyncratic drug reactions and membranous glomerulopathy
Abstract
An infant boy with steroid-resistant nephrotic syndrome (idiopathic membranous glomerulonephropathy) achieved remission with ciclosporin but developed eosinophilia and high IgE levels (max 19 000 iU/mL). Conversion to tacrolimus resulted in chronic diarrhoea (eosinophilic gastroenteritis), muscle weakness, polyserositis and failure-to-thrive. In contrast, a trial without tacrolimus resulted in a ciclosporin-responsive relapse, therapy-resistant focal seizures with generalised spikes, worsening muscle weakness and diarrhoea. The patient was weaned off of ciclosporin and completely normalised. In vitro testing demonstrated decreased viability of the patient's cells when incubated with calcineurin inhibitors (ciclosporin, 70%; tacrolimus, 80% compared to control cells), supporting their role in this adverse drug reaction.
2017 BMJ Publishing Group Ltd.
Conflict of interest statement
Competing interests: None declared.
Figures


Similar articles
-
Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.Transpl Int. 2012 Apr;25(4):391-400. doi: 10.1111/j.1432-2277.2011.01409.x. Epub 2011 Dec 27. Transpl Int. 2012. PMID: 22211928 Clinical Trial.
-
De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case.Int J Artif Organs. 1997 Jul;20(7):379-82. Int J Artif Organs. 1997. PMID: 9298410
-
Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects.Transpl Int. 2005 Jul;18(7):816-23. doi: 10.1111/j.1432-2277.2005.00154.x. Transpl Int. 2005. PMID: 15948861 Clinical Trial.
-
Calcineurin inhibitors in pediatric renal transplant recipients.Paediatr Drugs. 2007;9(3):165-74. doi: 10.2165/00148581-200709030-00005. Paediatr Drugs. 2007. PMID: 17523697 Review.
-
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.Clin Pharmacokinet. 2010 Apr;49(4):207-21. doi: 10.2165/11317550-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214406 Review.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical